Last reviewed · How we verify
major depressive disorder mdd
Approved treatments
Clinical guidelines
- FDA label — 1L
Paroxetine is indicated for the treatment of major depressive disorder in adults. - FDA label — 1L
TRINTELLIX is indicated for the treatment of major depressive disorder (MDD) in adults.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- major depressive disorder mdd patent landscape — cliff calendar, originator estates, attackable patents
- major depressive disorder mdd treatment landscape brief
- major depressive disorder mdd treatment updates RSS
Frequently asked questions about major depressive disorder mdd
What are the treatment guidelines for major depressive disorder mdd?
FDA label publishes guidelines for major depressive disorder mdd. 2 guideline references tracked.
Related
- Treatment landscape: major depressive disorder mdd patent cliff · major depressive disorder mdd CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing